Calamos Asset Management appoints two independent directors
The Calamos Asset Management board of directors has appointed Keith (Kim) Schappert and William (Bill) Shiebler as additional independent board members, effective 22 August 2012.
Schappert and Shiebler will also be added to the board's audit, compensation and nominating and corporate governance committees.
"We are quite pleased to have Kim and Bill join our board. They each contribute decades of asset management industry expertise, will enrich the dialogue among board members and add value for the shareholders of Calamos Asset Management," says John P. Calamos, Sr. (pictured), chairman, chief executive officer and global co-chief investment officer.
Schappert spent nearly 30 years at JP Morgan Investment Management, advancing from fixed income portfolio manager to president and chief executive officer. In 2001, Schappert became president and chief executive officer of Federated Investment Advisory Companies, later moving to Credit Suisse as regional head of the Americas for asset management. Since 2008, Schappert has operated his own consulting business and has served as director on a number of financial industry boards including MetLife Series Trust, Commonfund, Trilogy Global Advisors and Mirae Asset Management.
Shiebler was chief executive officer of the Americas for Deutsche Asset Management until his retirement in 2007. Prior to that, he served as senior managing director of Putnam Investments and president and chief executive of Putnam Mutual Funds. He also spent 12 years at Dean Witter Reynolds, departing as president and chief operating officer of the intercapital division and the firm's mutual fund business. Shiebler has served on a number of corporate and non-profit boards in the US and Europe and is currently active with a variety of business, community and charitable organisations. He was a trustee of Scudder Mutual Funds, was a member of the Presidential Commission on Medicaid, is a trustee of the United States Ski and Snowboard Team, and chairman of an advisory board for medical research at the University of Utah.
- Special Reports